Announced
Completed
Financials
Tags
United Kingdom
Biotechnology
machine learning
drug discovery
Private
Acquisition
Minority
Private Equity
Friendly
Cross Border
Venture Capital
Completed
Single Bidder
Synopsis
DCVC, a venture capital firm, and NVentures, a venture capital arm of NVIDIA, led a $35m round in Relation Therapeutics, a virtual drug discovery specialist, with participation from Magnetic Ventures, Khosla Ventures, Jonathan Milner, ARK Invest and Deerfield Management Company. "This financing is a significant milestone for Relation Therapeutics and underscores the confidence our investors have in our innovative approach to drug discovery and development. Our technology platform, uniquely integrated with deep R&D expertise, places us in an outstanding position to transform drug discovery. This new capital allows us to accelerate our discovery of novel biology, targets and medicines: we are immensely excited about our progress and the impact we can make for patients," David Roblin, Relation Therapeutics CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.